Literature DB >> 25703551

The onset of adaptive immunity in the mouse model of tuberculosis and the factors that compromise its expression.

Richard T Robinson1, Ian M Orme, Andrea M Cooper.   

Abstract

Mycobacterium tuberculosis (Mtb) has been evolving with its human host for over 50 000 years and is an exquisite manipulator of the human immune response. It induces both a strong inflammatory and a strong acquired immune response, and Mtb then actively regulates these responses to create an infectious lesion in the lung while maintaining a relatively ambulatory host. The CD4(+) T cell plays a critical yet contradictory role in this process by both controlling disseminated disease while promoting the development of the lesion in the lung that mediates transmission. In light of this manipulative relationship between Mtb and the human immune response, it is not surprising that our ability to vaccinate against tuberculosis (TB) has not been totally successful. To overcome the current impasse in vaccine development, we need to define the phenotype of CD4(+) T cells that mediate protection and to determine those bacterial and host factors that regulate the effective function of these cells. In this review, we describe the initiation and expression of T cells during TB as well as the fulminant inflammatory response that can compromise T-cell function and survival.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cells; infectious disease; inflammation; lung; vaccination

Mesh:

Substances:

Year:  2015        PMID: 25703551     DOI: 10.1111/imr.12259

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

Review 1.  Immunological roulette: Luck or something more? Considering the connections between host and environment in TB.

Authors:  John E Pearl; Mrinal Das; Andrea M Cooper
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 2.  Tuberculosis in the elderly: Why inflammation matters.

Authors:  Tucker J Piergallini; Joanne Turner
Journal:  Exp Gerontol       Date:  2017-12-26       Impact factor: 4.032

Review 3.  Cytokines and Chemokines in Mycobacterium tuberculosis Infection.

Authors:  Racquel Domingo-Gonzalez; Oliver Prince; Andrea Cooper; Shabaana A Khader
Journal:  Microbiol Spectr       Date:  2016-10

4.  What can immunology contribute to the control of the world's leading cause of death from bacterial infection?

Authors:  Carl Nathan
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

5.  pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence.

Authors:  Eva C Boritsch; Wafa Frigui; Alessandro Cascioferro; Wladimir Malaga; Gilles Etienne; Françoise Laval; Alexandre Pawlik; Fabien Le Chevalier; Mickael Orgeur; Laurence Ma; Christiane Bouchier; Timothy P Stinear; Philip Supply; Laleh Majlessi; Mamadou Daffé; Christophe Guilhot; Roland Brosch
Journal:  Nat Microbiol       Date:  2016-01-27       Impact factor: 17.745

Review 6.  Manipulation of BCG vaccine: a double-edged sword.

Authors:  V K Singh; R Srivastava; B S Srivastava
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-25       Impact factor: 3.267

7.  Balance between Protection and Pathogenic Response to Aerosol Challenge with Mycobacterium tuberculosis (Mtb) in Mice Vaccinated with TriFu64, a Fusion Consisting of Three Mtb Antigens.

Authors:  Sadaf Sulman; Benjamin O Savidge; Kawther Alqaseer; Mrinal K Das; Neda Nezam Abadi; John E Pearl; Obolbek Turapov; Galina V Mukamolova; M Waheed Akhtar; Andrea May Cooper
Journal:  Vaccines (Basel)       Date:  2021-05-18

8.  Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection.

Authors:  Xiangyang Wu; Yong Wu; Ruijuan Zheng; Fen Tang; Lianhua Qin; Detian Lai; Lu Zhang; Lingming Chen; Bo Yan; Hua Yang; Yang Wang; Feifei Li; Jinyu Zhang; Fei Wang; Lin Wang; Yajuan Cao; Mingtong Ma; Zhonghua Liu; Jianxia Chen; Xiaochen Huang; Jie Wang; Ruiliang Jin; Peng Wang; Qin Sun; Wei Sha; Liangdong Lyu; Pedro Moura-Alves; Anca Dorhoi; Gang Pei; Peng Zhang; Jiayu Chen; Shaorong Gao; Felix Randow; Gucheng Zeng; Chang Chen; Xin-Shan Ye; Stefan H E Kaufmann; Haipeng Liu; Baoxue Ge
Journal:  EMBO Rep       Date:  2021-05-13       Impact factor: 8.807

9.  Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.

Authors:  Egidio Torrado; Jeffrey J Fountain; Mingfeng Liao; Michael Tighe; William W Reiley; Rachel P Lai; Graeme Meintjes; John E Pearl; Xinchun Chen; Daniel E Zak; Ethan G Thompson; Alan Aderem; Nico Ghilardi; Alejandra Solache; K Kai McKinstry; Tara M Strutt; Robert J Wilkinson; Susan L Swain; Andrea M Cooper
Journal:  J Exp Med       Date:  2015-08-17       Impact factor: 14.307

10.  Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study.

Authors:  Anna Cristina C Carvalho; Gustavo Amorim; Mayla G M Melo; Ana Karla A Silveira; Pedro H L Vargas; Adriana S R Moreira; Michael S Rocha; Alexandra B Souza; María B Arriaga; Mariana Araújo-Pereira; Marina C Figueiredo; Betina Durovni; José R Lapa-E-Silva; Solange Cavalcante; Valeria C Rolla; Timothy R Sterling; Marcelo Cordeiro-Santos; Bruno B Andrade; Elisangela C Silva; Afrânio L Kritski
Journal:  Front Immunol       Date:  2021-07-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.